Gb Sciences, Michigan State University Team Up to Study Cannabinoid-Based Treatment of COVID-19 Symptoms

Cannabis Business Times
Jan 24, 2022, 3:00 pm247 pts
Last year, the team at Gb Sciences and a cohort of researchers at Michigan State University announced positive results from ongoing study into cannabinoid-based treatments for cytokine release syndrome (CRS). The work continues into 2022, with a paper awaiting publication, but the good news arrived at the onset…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Expect More R&B and Less Hip-Hop at 2025 Revelry Cannabis Festival 72

House To Vote On Expanding Marijuana Waivers For Military Recruits, But Separate Hemp Amendment Is Blocked From Defense Bill 71

Trump Admin Could Be ‘Revolutionary’ In Advancing Marijuana And Psychedelics Reform, Democratic Congressman Says 68

The Cannabist Co. Opening 6th Ohio Dispensary in Norwalk 65

Are cannabis consumers more loyal to brands, or products? 59

Texas Governor Expected To Issue Hemp Executive Order Setting Age Limit And Requirements For Testing And Labeling 39

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.